Flavonoid-Rich Lime Extract Attenuates Albuminuria in Diabetic Nephropathy

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

TCTR

Registry ID

TCTR20250530001

Enrollment

100

Registered

2025-05-30

Start date

2021-07-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic nephropathy with albuminuria Albuminuria Diabetes mellitus Lime extract Citrate Flavonoids

Interventions

Maltodextrin 15 g oral ingestion once a day for 6 months,Modified Shohl&#039

s solution with equvalent citrate dosage with LN oral ingestion once a day for 6 months,Lime extract (Limenase) 15 mg oral ingestion once a day for 6 months

Placebo Comparator No treatment,Active Comparator Dietary Supplement,Experimental Dietary Supplement

Placebo,Shohl,Limenase

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Diabetic patients with urinary albumin greater than 30 mg per day

Exclusion criteria

Exclusion criteria: 1. Patients who uses immunosuppresive drugs or monoclonal antibody 2. patients with acute upper urinary tract infection

Design outcomes

Primary

Measure	Time frame
Albuminuria 6 moth Chemiluminescense	—

Secondary

Measure	Time frame
Kidney innjury marker 6 month NephroCheck	—

Countries

Thailand

Contacts

Public ContactThasinas Dissayabutra

Chulalongkorn University

thasinas@chula.md022564482

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026